1 |
DOLMA S, LESSNICK S L, HAHN W C, et al.. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells[J]. Cancer Cell, 2003, 3(3): 285-296.
|
2 |
DIXON S J, LEMBERG K M, LAMPRECHT M R, et al.. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072.
|
3 |
FRIEDMANN A J, SCHNEIDER M, PRONETH B, et al.. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice[J]. Nat. Cell. Biol., 2014, 16(12): 1180-1191.
|
4 |
STOCKWELL B R, FRIEDMANN A J, BAYIR H, et al.. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell, 2017, 171(2): 273-285.
|
5 |
YANG W S, KIM K J, GASCHLER M M, et al.. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis[J/OL]. Proc. Natl. Acad. Sci. USA, 2016,113(34): E4966-E4975[2021-10-12]. .
|
6 |
CHENG Z, LI Y. What is responsible for the initiating chemistry of iron-mediated lipid peroxidation: an update[J]. Chem. Rev., 2007, 107(3): 748-766.
|
7 |
KAGAN V E, MAO G, QU F, et al.. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis[J]. Nat. Chem. Biol., 2017, 13(1): 81-90.
|
8 |
DOLL S, PRONETH B, TYURINA Y Y, et al.. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat. Chem. Biol., 2017,13(1): 91-98.
|
9 |
DOLL S, FREITAS F P, Shah R, et al.. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature, 2019, 575(7784): 693-698.
|
10 |
FENG H, STOCKWELL B R. Unsolved mysteries: How does lipid peroxidation cause ferroptosis? [J/OL]. PLoS Biol., 2018, 16(5): e2006203[2021-10-12]. .
|
11 |
DAHER R, MANCEAU H, KARIM Z. Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease[J/OL]. Presse. Med., 2017, 46(12 Pt 2):e272-e278[2021-10-12]. .
|
12 |
CAPELLETTI M M, MANCEAU H, PUY H, et al.. Ferroptosis in liver diseases: an overview[J/OL]. Int. J. Mol. Sci., 2020, 21(14): 4908[2021-10-12]. .
|
13 |
SHEN Z, LIU T, Li Y, et al.. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors[J]. ACS Nano., 2018, 12(11): 11355-11365.
|
14 |
GAO W, ZHAO J, GAO Z, et al.. Synergistic interaction of light alcohol administration in the presence of mild iron overload in a mouse model of liver injury: involvement of triosephosphate isomerase nitration and inactivation[J/OL]. PLoS ONE, 2017, 12(1): e170350[2021-10-12]. .
|
15 |
HAN C, LIU Y, DAI R, et al.. Ferroptosis and its potential role in human diseases[J/OL]. Front. Pharmacol., 2020, 11: 239[2021-10-12]. .
|
16 |
GAMMELLA E, RECALCATI S, RYBINSKA I, et al.. Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms[J/OL]. Oxid. Med. Cell. Longev., 2015, 2015:230182[2021-10-12]. .
|
17 |
LI J, CAO F, YIN H L, et al.. Ferroptosis: past, present and future[J/OL]. Cell. Death. Dis., 2020, 11(2): 88[2021-10-12]. .
|
18 |
HIRSCHHORN T, STOCKWELL B R. The development of the concept of ferroptosis[J]. Free. Radic. Biol. Med., 2019,133:130-143.
|
19 |
YANG W S, STOCKWELL B R. Ferroptosis: death by lipid peroxidation[J]. Trends. Cell. Biol., 2016,26(3):165-176.
|
20 |
GASCHLER M M, ANDIA A A, LIU H, et al.. FINO(2) initiates ferroptosis through GPX4 inactivation and iron oxidation[J]. Nat. Chem. Biol., 2018, 14(5): 507-515.
|
21 |
YAGODA N, MVON RECHENBERG, ZAGANJOR E, et al.. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels[J]. Nature,2007,447(7146):864-868.
|
22 |
SUN X, OU Z, XIE M, et al.. HSPB1 as a novel regulator of ferroptotic cancer cell death[J]. Oncogene, 2015, 34(45): 5617-5625.
|
23 |
DOLL S, FREITAS F P, SHAH R, et al.. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature,2019,575(7784): 693-698.
|
24 |
HOU W, XIE Y, SONG X, et al.. Autophagy promotes ferroptosis by degradation of ferritin[J]. Autophagy, 2016, 12(8): 1425-1428.
|
25 |
CHEN G Q, BENTHANI F A, WU J, et al.. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis[J]. Cell Death. Differ., 2020, 27(1): 242-254.
|
26 |
YANG M, CHEN P, LIU J, et al.. Clockophagy is a novel selective autophagy process favoring ferroptosis[J/OL]. Sci. Adv., 2019, 5(7): eaaw2238[2021-10-12]. .
|
27 |
DIXON S J, PATEL D N, WELSCH M, et al.. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis[J/OL]. Elife, 2014, 3: e2523[2021-10-12]. .
|
28 |
CHEN D, FAN Z, RAUH M, et al.. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner[J]. Oncogene, 2017, 36(40): 5593-5608.
|
29 |
SUN Y, CHEN P, ZHAI B, et al.. The emerging role of ferroptosis in inflammation[J/OL]. Biomed. Pharmacother., 2020, 127: 110108[2021-10-12]. .
|
30 |
LINKERMANN A, SKOUTA R, HIMMERKUS N, et al.. Synchronized renal tubular cell death involves ferroptosis[J]. Proc. Natl. Acad. Sci. USA, 2014,111(47):16836-16841.
|
31 |
KANG R, ZENG L, ZHU S, et al.. Lipid peroxidation drives gasdermin d-mediated pyroptosis in lethal polymicrobial sepsis[J]. Cell Host. Microbe., 2018, 24(1): 97-108.
|
32 |
QI J, KIM J W, ZHOU Z, et al.. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice[J]. Am. J. Pathol., 2020, 190(1):68-81.
|
33 |
LEVEY A S, JAMES M T. Acute kidney injury[J]. Ann. Intern. Med., 2017, 167(9):C66-C80.
|
34 |
HU Z, ZHANG H, YANG S K, et al.. Emerging role of ferroptosis in acute kidney injury[J/OL]. Oxid. Med. Cell. Longev., 2019, 2019: 8010614[2021-10-12]. .
|
35 |
TONNUS W, LINKERMANN A. The in vivo evidence for regulated necrosis[J]. Immunol. Rev., 2017, 277(1): 128-149.
|
36 |
SWAMINATHAN S. Iron homeostasis pathways as therapeutic targets in acute kidney injury[J]. Nephron, 2018, 140(2): 156-159.
|
37 |
FRIEDMANN A J, SCHNEIDER M, Proneth B, et al.. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice[J]. Nat. Cell. Biol., 2014, 16(12): 1180-1191.
|
38 |
LINKERMANN A, SKOUTA R, HIMMERKUS N, et al.. Synchronized renal tubular cell death involves ferroptosis[J]. Proc. Natl. Acad. Sci. USA, 2014,111(47):16836-16841.
|
39 |
ZARJOU A, BOLISETTY S, JOSEPH R, et al.. Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury[J]. J. Clin. Invest., 2013, 123(10): 4423-4434.
|
40 |
MARTIN-SANCHEZ D, RUIZ-ANDRES O, POVEDA J, et al.. Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI[J]. J. Am. Soc. Nephrol., 2017, 28(1): 218-229.
|
41 |
WANG Y, QUAN F, CAO Q, et al.. Quercetin alleviates acute kidney injury by inhibiting ferroptosis[J]. J. Adv. Res., 2021, 28: 231-243.
|
42 |
WEBSTER A C, NAGLER E V, MORTON R L, et al.. Chronic kidney disease[J]. Lancet, 2017, 389(10075): 1238-1252.
|
43 |
MENG X M, NIKOLIC-PATERSON D J, LAN H Y. Inflammatory processes in renal fibrosis[J]. Nat. Rev. Nephrol., 2014, 10(9): 493-503.
|
44 |
WEN Q, LIU J, KANG R, et al.. The release and activity of HMGB1 in ferroptosis[J]. Biochem. Biophys. Res. Commun., 2019, 510(2): 278-283.
|
45 |
YANG L, GUO J, YU N, et al.. Tocilizumab mimotope alleviates kidney injury and fibrosis by inhibiting IL-6 signaling and ferroptosis in UUO model[J/OL]. Life Sci., 2020, 261:118487[2021-10-12]. .
|
46 |
LI S, ZHENG L, ZHANG J, et al.. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy[J]. Free. Radic. Biol. Med., 2021, 162: 435-449.
|
47 |
DE ZEEUW D, AKIZAWA T, AUDHYA P, et al.. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease[J]. N. Engl. J. Med., 2013, 369(26): 2492-2503.
|
48 |
A-EDECLEVES, ZOLKIPLI Z, SATRIANO J, et al.. Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury[J]. Kidney Int., 2014, 85: 611-623.
|
49 |
LI C, DONG X, DU W, et al.. LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis[J/OL]. Signal. Transduct. Target. Ther., 2020, 5(1): 187[2021-10-12]. .
|
50 |
LEE H, ZANDKARIMI F, ZHANG Y, et al.. Energy-stress-mediated AMPK activation inhibits ferroptosis[J]. Nat. Cell. Biol., 2020, 22(2): 225-234.
|
51 |
Singer E A, Gupta G N, MARCHALIK D, et al.. Evolving therapeutic targets in renal cell carcinoma[J]. Curr. Opin. Oncol., 2013,25(3):273-280.
|
52 |
YANG W S, SRIRAMARATNAM R, WELSCH M E, et al.. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1-2): 317-331.
|
53 |
MAJMUNDAR A J, WONG W J, SIMON M C. Hypoxia-inducible factors and the response to hypoxic stress[J]. Mol. Cell., 2010, 40(2): 294-309.
|
54 |
MIESS H, DANKWORTH B, GOUW A M, et al.. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma[J]. Oncogene, 2018, 37(40): 5435-5450.
|